Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BYFrontiers in cardiovascular medicine

Effect of rosuvastatin and ezetimibe therapy on LDL-cholesterol reduction and non-invasive arterial injury markers in children with heterozygous familial hypercholesterolemia: a prospective, open-label, randomized study

  • Ajda Skarlovnik1
  • Tevz Gorjanc2
  • Jaka Sikonja2
  • Jan Kafol1
  • Matej Mlinaric3
  • Barbara Cugalj Kern2
  • Ana Drole Torkar2
  • Jernej Kovac2
  • Chiara Rodaro4
  • Tadej Battelino2
  • Urh Groselj2
4 affiliations
  1. 1Department of Vascular Diseases, Division of Internal Medicine, University Medical Centre Ljubljana , ,
  2. 2Faculty of Medicine, University of Ljubljana , ,
  3. 3Department of Endocrinology, Diabetes, and Metabolic Diseases, University Children's Hospital, University Medical Centre Ljubljana , ,
  4. 4Clinical Department of Medical, Surgical and Health Science, University of Trieste , ,
Read full textPDFCite

Related

  1. Cholesterol-Mediated Modulation of Collecting Lymphatic Vessel Contractility: Exploring Cholesterol Depletion as a Therapeutic Alternative to Improve Lymphatic Function in Hypercholesterolemia
    K. Keane, J. A. Castorena-Gonzalez
    bioRxivPreprintAll rights reservedFull textPhysiologybioRxiv
  2. Prevalence and Impact of a Pathogenic CYP27A1 Variant on the Phenotypes Among Patients with Monogenic Heterozygous Familial Hypercholesterolemia
    Hayato Tada, Atsushi Furukawa, Masayuki Takamura
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  3. Polygenic risk score assessment of LDL-Cholesterol levels and progression to severe hypercholesterolemia and statin treatment; a longitudinal study from a large middle eastern biobank
    Umm-Kulthum Ismail Umlai, Salman M Toor, Usama Aliyu +7
    American journal of preventive cardiologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Reclassification of Clinical Familial Hypercholesterolemia Diagnoses After Adjustment of LDL-C for Lipoprotein(a) Cholesterol: A Systematic Review and Meta-Analysis
    Grzegorz Procyk, Adam Sukiennik, Jakub Michal Zimodro
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  5. Estimated Small Dense LDL Cholesterol and Coronary Artery Disease in Familial Hypercholesterolemia
    Dimitrios Delialis, Christos V. Rizos, Evmorfia Aivalioti +38
    Journal of Atherosclerosis and ThrombosisPeer-reviewedCC BY-NC-SAFull textSurgery & anaesthesiaJ-STAGE

Cite

BibTeXRIS
BibTeX
@article{skarlovnik2026effect,
  title = {{Effect of rosuvastatin and ezetimibe therapy on LDL-cholesterol reduction and non-invasive arterial injury markers in children with heterozygous familial hypercholesterolemia: a prospective, open-label, randomized study}},
  author = {Ajda Skarlovnik and Tevz Gorjanc and Jaka Sikonja and Jan Kafol and Matej Mlinaric and Barbara Cugalj Kern and Ana Drole Torkar and Jernej Kovac and Chiara Rodaro and Tadej Battelino and Urh Groselj},
  journal = {Frontiers in cardiovascular medicine},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13657965},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Effect of rosuvastatin and ezetimibe therapy on LDL-cholesterol reduction and non-invasive arterial injury markers in children with heterozygous familial hypercholesterolemia: a prospective, open-label, randomized study
AU  - Ajda Skarlovnik
AU  - Tevz Gorjanc
AU  - Jaka Sikonja
AU  - Jan Kafol
AU  - Matej Mlinaric
AU  - Barbara Cugalj Kern
AU  - Ana Drole Torkar
AU  - Jernej Kovac
AU  - Chiara Rodaro
AU  - Tadej Battelino
AU  - Urh Groselj
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in cardiovascular medicine
UR  - https://europepmc.org/article/PMC/PMC13657965
SN  - 2297-055X
ER  -